• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Guangdong’s Pilot Plan for Hong Kong Medical Devices to enter the China Greater Bay Area

Guangdong’s Pilot Plan for Hong Kong Medical Devices to enter the China Greater Bay Area

Wednesday, 24 March 2021 / Published in Medical Device, News, NMPA Registration in China

Guangdong’s Pilot Plan for Hong Kong Medical Devices to enter the China Greater Bay Area

On January 28, 2021, the Guangdong MPA (Medical Products Administration) announced the pilot plan (No.5-2021) to introduce Hong Kong medical devices into the China Greater Bay Area via the University of Hong Kong-Shenzhen Hospital as a start.

In the announcement, the Guangdong MPA addressed the following responsibilities of the different departments involved to support the pilot plan:

DepartmentResponsibilities
Guangdong MPA
Fully support the pilot phase for the University of Hong Kong-Shenzhen Hospital to use drug and medical device products from Hong Kong and Macao

Formulate a review report and recommendation plan after the pilot phase ends on July 31, 2021

Health Commission
of Guangdong Province

Implement the internal evaluation process and standard requirements for the approval of GBA medical institutions to use drug and medical device products from Hong Kong and Macao


Guangdong Provincial Development and
Reform Commission


Strengthen the policy implementation and follow up for confirmation

Department of Finance
of Guangdong Province

Consolidate the designated medical institutions’ requests for import tariff reductions and submit them to the Ministry of Finance for approval


Guangdong
Sub-administration
of GACC (General Administration of Customs. P.R. China)


Coordinate with the related customs departments of Hong Kong, Macao and the nine Pearl River Delta municipalities to deliver proper custom clearance procedures

The pilot plan came into force on January 28, 2021 and will end on July 31, 2021.

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Greater Bay Area

What you can read next

AI Regulatory Developments and Planning Issued by China Regulator
China’s Regulatory Pathway for Customized Medical Devices (CMDs)
Standardizing the Classification of Medical Devices

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.